公开(公告)号：EP2311859A1

公开(公告)日：2011-04-20

申请号：EP10176984.2

申请日：2004-06-30

申请人： Bayer Animal Health GmbH

发明人： Greif, Dr. Gisela ,  Hosse, Ralf ,  Krücken, Dr. Jürgen ,  Wunderlich, Prof. Dr. Frank

IPC分类号： C07K14/44 ,  A61K39/395 ,  A61K39/012

CPC分类号： C07K16/20 ,  A61K39/012 ,  A61K2039/505 ,  A61K2039/53 ,  C07K14/455

摘要： The invention relates to a novel oocyst sporocyst protein ( Et OS22) belonging to the parasite of the species Eimeria tenella and to the polynucleotide encoding this protein, to vectors which contain this polynucleotide, to cells which are transformed with these vectors, to antibodies which are directed against the protein, to vaccines which comprise the polynucleotide, the protein, or fragments thereof, the abovementioned vectors or antibodies directed against the protein, and to the use of polynucleotide or of polypeptide for finding active compounds for treating an infection with Eimeria and active compounds which are suitable for the therapy of an infection with Eimeria.

摘要翻译： 本发明涉及属于艾美球虫种类的寄生虫和编码该蛋白质的多核苷酸的新型卵囊孢子囊蛋白（Et OS22）与含有该多核苷酸的载体对于用这些载体转化的细胞， 针对蛋白质的疫苗，涉及包含多核苷酸，蛋白质或其片段的疫苗，针对蛋白质的上述载体或抗体，以及多核苷酸或多肽用于寻找用于治疗艾美球虫感染和活性物质的活性化合物的用途 适用于艾美球虫感染治疗的化合物。